NCT00975286 · Interventional trial
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
Overall registry status Completed
Phase 3
Conditions Type 2 Diabetes Mellitus
Delaware Valley sites
- Sanofi-Aventis Investigational Site Number 840202 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory